John has over 30 years of business experience working with both public and private companies. His primary interest and experience is with start up and emerging growth biopharma and high technology companies.   He has worked with a multitude of companies both as an external Audit Partner advisor and as the CFO.

John’s experience spans strategic, financial and business planning, IPOs, equity and debt financings, and merger and acquisition analysis, execution and integration, both domestically and internationally. During his career he has been responsible for closing a $75 million IPO with investor indications of interest that exceeded eight times the number of shares being offered, and completed two separate acquisitions: a domestic operation acquired from a major U.S. chemical company and an independent company located in the U.K.

Prior to becoming a partner at FLG, John was the CFO for a privately-held web-based software and data company providing clinical trial services to pharmaceutical and biotech companies. As Chief Financial Officer of Argonaut Technologies, John was recruited to file the Company’s S-1 registration statement and to represent the Company during the investor road show. He also served as the Chief Financial Officer of Beacon Diagnostics, a diagnostics company. He is a Certified Public Accountant and spent approximately half of his career with Ernst & Young LLP. He began his career at Alza Corporation, a publicly traded drug delivery systems company. John recently served as the CFO for Peak International Limited (NASDAQ: PEAK), a Hong Kong-based precision plastics injection molding company serving the high tech industry.

John holds a BS degree in Business Administration (Accounting) from California State University, San Jose, and is an inactive Certified Public Accountant in California. In June 2005, John attended the Stanford University School of Law, Directors’ College.